Last reviewed · How we verify

mupirocin 2% ointment

Philippine Dermatological Society · Phase 3 active Small molecule

Mupirocin 2% ointment works by inhibiting bacterial protein synthesis, specifically targeting isoleucyl-tRNA synthetase.

Mupirocin 2% ointment works by inhibiting bacterial protein synthesis, specifically targeting isoleucyl-tRNA synthetase. Used for Treatment of impetigo, secondarily infected eczema, and minor cuts and scrapes.

At a glance

Generic namemupirocin 2% ointment
Also known asMupirocin
SponsorPhilippine Dermatological Society
Drug classbacterial protein synthesis inhibitor
Targetisoleucyl-tRNA synthetase
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

This inhibition prevents the bacteria from producing essential proteins, ultimately leading to cell death. Mupirocin is a potent inhibitor of bacterial growth, particularly effective against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus pyogenes.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results